PCI Pharma Services (PCI)is pleased to announce we have signed a definitive agreement to acquire Lyophilization Services of New England, Inc. (LSNE), a premier contract development and manufacturing organization (CDMO) headquartered in Bedford, New Hampshire, from global private equity firm Permira
Tim Roberts, VP Global Sales, PCI Pharma Services, talked with Salesforce recently about how we’re rapidly innovating to keep up with the “new normal,” increasing its efficiency and agility to bring life-changing therapies to patients faster. With Salesforce in place, we have shortened the creation of clinical trial proposals from five days to just 30 […]
PCI Focuses on Global Growth to Meet Evolving Client Needs PCI Pharma Services is pleased to announce that John Cullivan has joined the Company as a new member of the Executive Leadership Team in the role of Chief Corporate Development Officer. John will play a key role in PCI’s growth strategy and will accelerate our […]
PCI Pharma Services is today pleased to announce a new milestone in our global Clinical footprint with the expansion of cold chain clinical supply storage and distribution capabilities at our Berlin location, a major investment that will provide global access to regional customers. The Berlin facility recently passed mandatory regulatory inspection for these expansions, and […]
PCI Pharma Services is pleased to announce that Tom De Weerdt has joined the Company as Senior Vice President (SVP), Chief Financial Officer (CFO). Mr. De Weerdt succeeds Serge Dupuis, who is retiring. “Serge has been an outstanding CFO for PCI, helping lead the Company through the past two years of unprecedented growth,” said Salim […]
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Your bridge between life-changing therapies and patients